MEVACOR Drug Patent Profile
✉ Email this page to a colleague
When do Mevacor patents expire, and when can generic versions of Mevacor launch?
Mevacor is a drug marketed by Merck and is included in one NDA.
The generic ingredient in MEVACOR is lovastatin. There are thirty-three drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mevacor
A generic version of MEVACOR was approved as lovastatin by ACTAVIS ELIZABETH on December 17th, 2001.
Summary for MEVACOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 127 |
Clinical Trials: | 27 |
Patent Applications: | 4,363 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MEVACOR |
DailyMed Link: | MEVACOR at DailyMed |
Recent Clinical Trials for MEVACOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Heart Health Research Center | Phase 4 |
AstraZeneca | Phase 4 |
Amgen | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for MEVACOR
US Patents and Regulatory Information for MEVACOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-002 | Mar 28, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-003 | Aug 31, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-004 | Dec 14, 1988 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MEVACOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-004 | Dec 14, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-002 | Mar 28, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-003 | Aug 31, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MEVACOR
See the table below for patents covering MEVACOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 535944 | ⤷ Try a Trial | |
Finland | 801857 | ⤷ Try a Trial | |
Poland | 224920 | ⤷ Try a Trial | |
Ireland | 49685 | POLYHYDRO-3,7-DIMETHYL-8-(2-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)-ETHYL)-1-NAPHTHYLENYL-2-METHYLBUTANOATES,CORRESPONDING HYDROXY ACIDS,PROCESS FOR PREPARING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | ⤷ Try a Trial |
Japan | S6366306 | ⤷ Try a Trial | |
Norway | 155699 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |